Display Settings:

Format

Send to:

Choose Destination
    Biomarkers. 2011 Mar;16(2):181-91. Epub 2011 Jan 14.

    Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers.

    Source

    Division of Allergy and Clinical Immunology, University of Colorado Denver, Aurora, CO 80045, USA. Brian.Tooker@ucdenver.edu

    Abstract

    OBJECTIVES:

    To identify biomarkers for cancer in asbestosis patients.

    METHODS:

    SELDI-TOF and CART were used to identify serum biomarker profiles in 35 asbestosis patients who subsequently developed cancer and 35 did not develop cancer.

    RESULTS:

    Three polypeptide peaks (5707.01, 6598.10, and 20,780.70 Da) could predict the development of cancer with 87% sensitivity and 70% specificity. The first two peaks were identified as KIF18A and KIF5A, respectively, and are part of the Kinesin Superfamily of proteins.

    CONCLUSIONS:

    We identified two Kinesin proteins that can be potentially used as blood biomarkers to identify asbestosis patients at risk of developing lung cancer.

    PMID:
    21231887
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Informa Healthcare

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk